Immune Design Reports Second Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- S&P 500 and Nasdaq end higher on cool inflation data, solid bank earnings
- IBM plunges 19% as memory capex squeeze derails Q2 earnings
- Fed’s Warsh says central bank won’t tolerate high inflation
- Software stocks tumble: High memory prices cannibalize enterprise tech capex
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
- IBM misses Q2 targets as mainframe and software sales disappoint
- Verizon planning new round of layoffs this week - Barron’s
- Goldman Sachs Upgrades NIO (NIO) to Buy
- BofA Securities on AppLovin: 'Current valuation appears reasonable'
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
Immune Design (IMDZ) Files $250M Common Stock Shelf
August 12, 2015 4:31 PM EDTImmune Design (NASDAQ: IMDZ) filed a registration with the U.S. SEC to sell up to $250 million of its common stock.
... MoreImmune Design (IMDZ) Misses Q2 EPS by 7c
August 12, 2015 4:30 PM EDTImmune Design (NASDAQ: IMDZ) reported Q2 EPS of ($0.54), $0.07 worse than the analyst estimate of ($0.47).
For earnings history and earnings-related data on Immune Design (IMDZ) click here.
... More